Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
ICPT - As of  06/21/24, 12:06:12 AM:   18 Insider Transactions.

Sector: Unknown    Industry: Unknown
Prev Close:$0.00  Avg Vol(3m): 0  P/E: 0.00  EPS: 0.00

Email this page to a friend.    Insider Transactions for ICPT

Buy/Sell* Filed Date Subject Symbol Acquirer Pct Owned Details
B 2020-08-31 16:30:16.0 INTERCEPT PHARMACEUTICALS ICPT Genextra S 12.2% view
S 2020-05-15 17:24:07.0 INTERCEPT PHARMACEUTICALS ICPT Genextra S 2.05% view
B 2020-02-12 11:08:36.0 INTERCEPT PHARMACEUTICALS ICPT VANGUARD GROUP INC 7.01% view
B 2019-07-31 16:30:21.0 INTERCEPT PHARMACEUTICALS ICPT Genextra S 20.6% view
B 2019-02-13 06:25:29.0 INTERCEPT PHARMACEUTICALS ICPT VANGUARD GROUP INC 6.76% view
B 2019-02-11 11:06:20.0 INTERCEPT PHARMACEUTICALS ICPT BlackRock Inc 6.9% view
B 2019-02-08 16:08:22.0 INTERCEPT PHARMACEUTICALS ICPT Genextra S 20.6% view
S 2018-12-07 14:52:06.0 INTERCEPT PHARMACEUTICALS ICPT JPMORGAN CHASE & CO 4.3% view
S 2018-04-12 11:29:58.0 INTERCEPT PHARMACEUTICALS INC ICPT Genextra S 10.61% view
S 2018-02-13 17:33:03.0 INTERCEPT PHARMACEUTICALS INC ICPT Capital World Investors 4.6% view
B 2018-02-13 09:39:49.0 INTERCEPT PHARMACEUTICALS INC ICPT FMR LLC 14.999% view
B 2018-02-08 15:05:45.0 INTERCEPT PHARMACEUTICALS INC ICPT VANGUARD GROUP INC 5.6% view
S 2018-02-06 12:17:10.0 INTERCEPT PHARMACEUTICALS INC ICPT Carmignac Gestion 0.0% view
B 2018-01-10 13:01:08.0 INTERCEPT PHARMACEUTICALS INC ICPT JPMORGAN CHASE & CO 7.9% view
S 2017-11-09 16:46:55.0 INTERCEPT PHARMACEUTICALS INC ICPT AMERIPRISE FINANCIAL INC 4.72% view
B 2017-02-14 11:24:40.0 INTERCEPT PHARMACEUTICALS INC ICPT FMR LLC 14.999% view
B 2017-02-13 17:03:42.0 INTERCEPT PHARMACEUTICALS INC ICPT Capital World Investors 8.6% view
S 2017-02-10 11:50:02.0 INTERCEPT PHARMACEUTICALS INC ICPT AMERIPRISE FINANCIAL INC 10.11% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.